Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001641172-25-007886
Filing Date
2025-04-30
Accepted
2025-04-30 17:15:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa14a.htm DEFA14A 14542
2 GRAPHIC formdefa14a_001.jpg GRAPHIC 1033267
3 GRAPHIC formdefa14a_002.jpg GRAPHIC 672932
  Complete submission text file 0001641172-25-007886.txt   2361576
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41210 | Film No.: 25897476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)